Leverantörer
Om TOSOH Bioscience
Headquartered in Tokyo, Tosoh is a comprehensive group of world-class companies located on almost every corner of the globe.
Tosoh Corporation is a Japanese chemical company established in 1935 and listed on the Prime market of the Tokyo Stock Exchange. It is the parent of the Tosoh Group, which comprises over 100 companies worldwide and a multiethnic workforce of over 13,000 people and generated net sales of ¥1,005.6 billion (US$6.7 billion at the average rate of ¥150 to the US dollar) in fiscal 2024, ended March 31, 2024.
Tosoh Bioscience has throughout the years demonstrated Technological Leadership in a number of Diagnostics niche markets including Immunochemistry, HPLC based diabetes and thalassemia screening and Molecular Biology.
This leadership is based on an in-depth understanding of the ever growing clinical demand for faster and more precise diagnosis of a number of life threatening pathologies (e.g. tumour, cardiac, diabetes etc).
It is also based on the analysis of operational requirements emanating from laboratories worldwide, where quality of results, be it essential, is just not good enough anymore.
Headquartered in Tokyo, Tosoh is a comprehensive group of world-class companies located on almost every corner of the globe.
Tosoh Corporation is a Japanese chemical company established in 1935 and listed on the Prime market of the Tokyo Stock Exchange. It is the parent of the Tosoh Group, which comprises over 100 companies worldwide and a multiethnic workforce of over 13,000 people and generated net sales of ¥1,005.6 billion (US$6.7 billion at the average rate of ¥150 to the US dollar) in fiscal 2024, ended March 31, 2024.
Just a few examples of how Tosoh Bioscience reconciles quality of results and workflow optimisation include:
Standardisation across platforms with a unitary dry chemistry reagent concept;
Workload management through flexible capacity loading options;
Connections to most automated production units;
Extended calibration stability;
One of the industry’s best ””up-time”” performance for our analysers.
Tosoh Bioscience’s recent breakthrough in Molecular Biology, with its TRC 160 platform, is a further demonstration of our capacity to address shortcomings of solutions currently available in the marketplace for the real-time diagnosis of, for example, tuberculosis.
Varför vi arbetar med TOSOH Bioscience
Oleinitec are proud to be representing TOSOH Bioscience. Their state of the art instruments are exactly what we want to represent on the market.
The collaboration started in 2024 and we aim to develop this to a long term relationship. To start with, we are focusing on the GPC instruments and column.
Gel permeation chromatography (GPC) is a type of size exclusion chromatography (SEC) that separates molecules according to their hydrodynamic volume which is related to their molecular weight. The separation is based strictly on the size of the sample in solution, and there should be no interaction with the stationary phase of the GPC column. Elution order in GPC is that of an “inverse-sieving” technique, large molecules access a smaller pore volume than smaller molecules resulting in larger molecules eluting from the GPC column prior to the smaller molecules.
Populära produkter från denna leverantör
Vi är här för att hjälpa dig
Behöver du hjälp med att välja ut rätt produkter för ditt företag? Ta kontakt med en expert!
